1. Home
  2. POET vs MPLT Comparison

POET vs MPLT Comparison

Compare POET & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo POET Technologies Inc.

POET

POET Technologies Inc.

HOLD

Current Price

$6.83

Market Cap

843.0M

Sector

Technology

ML Signal

HOLD

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$18.02

Market Cap

811.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
POET
MPLT
Founded
1972
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
843.0M
811.3M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
POET
MPLT
Price
$6.83
$18.02
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$31.00
AVG Volume (30 Days)
5.5M
139.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2,939.08
N/A
Revenue Next Year
$710.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.10
$12.24
52 Week High
$9.41
$21.55

Technical Indicators

Market Signals
Indicator
POET
MPLT
Relative Strength Index (RSI) 58.24 53.42
Support Level $5.05 $16.06
Resistance Level $7.66 $20.20
Average True Range (ATR) 0.45 1.22
MACD 0.18 0.05
Stochastic Oscillator 76.00 37.34

Price Performance

Historical Comparison
POET
MPLT

About POET POET Technologies Inc.

POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.

Share on Social Networks: